Short Interest in Nexien BioPharma, Inc. (OTCMKTS:NXEN) Decreases By 33.3%

Nexien BioPharma, Inc. (OTCMKTS:NXEN) was the recipient of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 200 shares, a decrease of 33.3% from the August 15th total of 300 shares. Based on an average trading volume of 22,200 shares, the short-interest ratio is presently 0.0 days.

Shares of OTCMKTS NXEN traded up $0.01 during mid-day trading on Monday, reaching $0.09. The company’s stock had a trading volume of 2,500 shares, compared to its average volume of 27,238. The company has a debt-to-equity ratio of 0.36, a quick ratio of 6.44 and a current ratio of 6.44. The stock has a fifty day moving average of $0.08 and a two-hundred day moving average of $0.11. Nexien BioPharma has a 52 week low of $0.03 and a 52 week high of $0.26.

About Nexien BioPharma

Nexien BioPharma, Inc engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. It also invests in companies with technologies or medications focused on cannabinoid-based research.

Featured Story: Why are percentage gainers important?

Receive News & Ratings for Nexien BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexien BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.